Home
Home | New Titles | Focus Reports | Custom Research | Browse Catalog  |  About Us |  Contact Us   |  

View Cart  |  Complete Purchase  |  View Wish List  |  My Reading Room  |  Edit Account  |  Purchase History  |  Register  |  Login  
       
In Vitro Diagnostics to 2013

 


View a more recent version of this report 





Study #: 2455
Document Type: Industry Study
Date Published: Mar-2009
Format:
   Full study: PDF
   Section, Pages, Tables and Charts: HTML
Pages: 373
Full Study Price: $4,800.00
       

    

US demand for in vitro diagnostic (IVD) products is forecast to increase 5.4 percent annually through 2013. Clinical chemistry and immunoassay will remain the top two IVD methodologies. Nucleic acid testing products will generate the fastest demand gains while endocrine condition testing remains the largest application.

This study analyzes the $17.6 billion US IVD industry. It presents historical demand data for the years 1998, 2003 and 2008, and forecasts for 2013 and 2018 by product type (e.g., reagents and consumables, instruments and systems, clinical chemistry, immunoassay, blood testing, nucleic acid testing, microbiology, cellular analysis), application (e.g., endocrine conditions, infectious diseases, cancer, drug testing) and market.

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 22 industry players, including Johnson & Johnson, Roche Holding and Siemens Healthcare Diagnostics.

 









Freedonia Footer Links
Career Opportunities   Press Contact   Partner Programs   User Agreement   Privacy Policy   FAQ’s/Help   Site Map   Study Index




E-mail: info@freedoniagroup.com • telephone: +1 440.684.9600 • fax: +1 440.646.0484      
767 Beta Dr. Cleveland Ohio 44143 USA

Copyright © 2013 - Freedonia - All Rights Reserved